DONNA SMITH: Open Payments
NPI 1942594833 · SUFFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 33 payments from 11 companies in 2025. Trend: 2023 $1,281 · 2024 $1,346 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $141 |
| ABBVIE INC. | 12 | $141 |
| Boston Scientific Corporation | 3 | $82 |
| Novo Nordisk Inc | 3 | $62 |
| Lilly USA, LLC | 3 | $60 |
| Janssen Biotech, Inc. | 2 | $57 |
| Gilead Sciences, Inc. | 2 | $49 |
| Abbott Laboratories | 1 | $26 |
| Endo USA, Inc. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: VRAYLAR, AIRSUPRA, WATCHMAN FLX, MOUNJARO, TREMFYA, Wegovy, BREZTRI, FREESTYLE LIBRE 3.
Industry payments across VA — which companies pay providers there.
